Pages that link to "Q37802079"
Jump to navigation
Jump to search
The following pages link to Continued control of pneumococcal disease in the UK - the impact of vaccination. (Q37802079):
Displaying 30 items.
- Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae (Q30399651) (← links)
- Lifestyle risk factors for invasive pneumococcal disease: a systematic review (Q33795662) (← links)
- Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. (Q33798133) (← links)
- Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. (Q34407129) (← links)
- What effect has pneumococcal vaccination had on acute mastoiditis? (Q34491998) (← links)
- The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe (Q34512593) (← links)
- Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine (Q34749756) (← links)
- A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults (Q36015061) (← links)
- Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy (Q36118755) (← links)
- Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review. (Q36219932) (← links)
- Parallel Evolution in Streptococcus pneumoniae Biofilms. (Q36983096) (← links)
- Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine (Q37309259) (← links)
- Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage (Q37559933) (← links)
- Experimental human pneumococcal carriage models for vaccine research (Q37904464) (← links)
- Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies (Q37956384) (← links)
- Fourteen years in resistance (Q37990212) (← links)
- Pharmacotherapy for pneumococcal infections: an update (Q38068919) (← links)
- Serotype-independent pneumococcal vaccines. (Q38069943) (← links)
- Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines. (Q38079159) (← links)
- Glycoconjugate vaccines: an update. (Q38286346) (← links)
- Invasive pneumococcal infection despite 7-valent conjugated vaccine (Q38678793) (← links)
- Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice. (Q39770701) (← links)
- Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD. (Q43711906) (← links)
- Have changing pneumococcal vaccination programmes impacted disease in Ontario? (Q43719622) (← links)
- Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice. (Q43832646) (← links)
- Prevenar experience (Q46751627) (← links)
- Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation (Q50848325) (← links)
- Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media (Q51168324) (← links)
- Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection (Q90461757) (← links)
- Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection (Q93357615) (← links)